Tianyin Completes Government Commission For Post-quake Medicines, Expects Expanded Revenue Despite Disruption In Operation
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Tianyin Pharmaceutical recently completed a special government commission for traditional Chinese medicines and western drugs as part of a massive relief effort following a magnitude 7.9 earthquake that ripped through the western Chinese province of Sichuan in May
You may also be interested in...
China's Tianyin Pharmaceutical Receives Approval For Ofloxacin And Fleroxacin To Expand Antibiotic Product Line
SHANGHAI - Tianyin Pharmaceutical, a Traditional Chinese Medicine and Western drug maker in China, announced it received manufacturing licenses from China's State FDA for its antibiotic products fluoroquinolone-based ofloxacin and quinolone broad-spectrum fleroxacin
China's Tianyin Pharmaceutical Receives Approval For Ofloxacin And Fleroxacin To Expand Antibiotic Product Line
SHANGHAI - Tianyin Pharmaceutical, a Traditional Chinese Medicine and Western drug maker in China, announced it received manufacturing licenses from China's State FDA for its antibiotic products fluoroquinolone-based ofloxacin and quinolone broad-spectrum fleroxacin
China’s Mindray Rushes To Meet Demand Surge for Patient Monitors Following May Earthquake
BEIJING - With a spike in orders for patient monitors following China's 7.9 magnitude earthquake, Mindray Medical International has ramped up production to supply hospitals throughout the devastated region